Dyne Therapeutics, Inc. · NASDAQ:DYN
Cox John sold 2,683 Dyne Therapeutics, Inc. shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 17, 2026
On Jun 16, 2026, Cox John (Director, CEO & President) sold 2,683 Dyne Therapeutics, Inc. shares at US$18.33 for US$49,179 under a trading plan, leaving 368,151 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 2,683 shares
- Price
- US$18.33
- Value
- US$49,179
- Holding after
- 368,151 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO & President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Sale | 2,683 | US$18.33 | 368,151 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Cox John
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Cox John · Aug 17, 2026
- Form 4 · Cox John · May 14, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026
- Form 4 · Friedl-Naderer Johanna · Aug 17, 2026